I-MED Pharma’s I-PEN® Does Not Infringe the TearLab Patent
In Canadian patent law, an obvious patent claim is null and unenforceable; as if it never existed. The I-PEN® does not infringe any valid claim of the TearLab Patent. I-MED decisively won this case, is free to continue offering the I-PEN® Osmolarity System to its customers and is entitled to... Continue reading